Loading data for PBH — first visit, this takes a few seconds.

Alert

Prestige Consumer Healthc... (PBH)

NYSE: PBH · Real-Time Price · USD

52.47

+1.26 (2.46%)

At close: Aug 28, 2026, 8:00 PM

52.47

+0.00%

After-hours: 7:30 PM

The price, the headline numbers and the latest news, in one place.

2.46% (1D)

No data available

Bid	51.21
Market Cap	2.49B
Revenue (ttm)	1.1B
Net Income (ttm)	172.01M
	0.33
	3.66
	14.34
	10.33
P/B (ttm)	1.30
P/S (ttm)	2.25
Earnings Date	Nov 5, 2026

Ask	52.27
Volume	299,756
Avg. Volume (20D)	594,009
Open	51.50
Previous Close	51.21
Day's Range	51.26 - 52.52
52-Week Range	42.62 - 71.07
Analyst	n/a
Price Target	n/a
Dividends	n/a
Ex-Dividend Date	Dec 27, 2013

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for ba...

Sector Healthcare

IPO Date Feb 10, 2005

Employees 890

Stock Exchange NYSE

Ticker Symbol PBH

Website https://www.prestigebrands.com

Full Company Profile

Financial Performance

In 2026, Prestige Consumer Healthcare's revenue was 1.09B, a decrease of -4.31% compared to the previous year's 1.14B. Earnings were 190.3M, a decrease of -11.32%.

Financial Statements

Earnings Surprise

Prestige Consumer Healthcare has released their quarterly earnings on Aug 6, 2026:

Revenue of $265.71M misses estimates by $0, with 6.48% YoY growth.
EPS of 0.98 exceeds estimates by 0.10, with 3.16% YoY growth.

Next Earnings Release

Prestige Consumer Healthcare Inc. is scheduled to release its earnings on Nov 5, 2026, before market opens.
Analysts project revenue of ... Upgrade

News

2 weeks ago · Insider Monkey

Prestige Consumer Healthcare (PBH) Bets Big On M&A, But Can Clear Eyes Recover?

Prestige Consumer Healthcare (NYSE:PBH) closed two acquisitions within three weeks this summer, adding roughly $240 million in annualized revenue to a portfolio anchored by Dramamine and Compound W. T...

2 weeks ago · Motley Fool

Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript

Acquisitions drive 6.5% revenue growth and portfolio diversification.

2 weeks ago · Zacks

PBH or SYK: Which Is the Better Value Stock Right Now?

PBH vs. SYK: Which Stock Is the Better Value Option?

3 weeks ago · MarketBeat

Prestige Consumer Healthcare Q1 Earnings Call Highlights

Prestige Consumer Healthcare (NYSE:PBH) reported first-quarter fiscal 2027 revenue growth of 6.5%, supported by broad-based category strength, the initial contribution from its Breathe Right acquisiti...

3 weeks ago · Simply Wall St.

Prestige Consumer Healthcare (PBH) Is Up 9.2% After Raising 2027 Outlook On Recent Acquisitions

In early August 2026, Prestige Consumer Healthcare reported fiscal 2027 first‑quarter revenue of US$265.71 million, up from US$249.53 million a year earlier, and raised its full‑year 2027 revenue outl...

Page 1 of 2